Jay S. Yadav MD is Founder and CEO of MiRus. Dr. Yadav has a long history of innovation and commercialization of novel technology focused on the development of new treatments for disease. Jay is an interventional cardiologist and founder of a number of successful companies: CardioMEMS acquired by St. Jude Medical; Angioguard, Inc. acquired by Johnson & Johnson; first investor and director of SMART Therapeutics acquired by Boston Scientific.
Jay has authored over 200 peer reviewed publications, 2 books and over 40 patents. His scientific and entrepreneurial work has been widely recognized: American Heart Association Top Ten Scientific Advances, 2003; Ellis Island Medal of Honor, 2004; 50 Best Doctors in the History of the Cleveland Clinic, 2011; Ernst and Young Entrepreneur of the Year (healthcare), 2011; Intel Innovation Award, 2011; his procedure for stroke treatment became a Class I recommendation of the American Heart Association and the American College of Cardiology, 2011; American Heart Association Honoree, 2016.
He serves on a number of non-profit boards including Georgia Bio (Chairman), GCMI (Global Center for Medical Innovation), TiE, American Heart Association, Southeast Medical Device Association, Beacon College, the Westminster Schools and the Advisory Board on Entrepreneurship for the Yale School of Management.
Experience
- Founder and CEO – MiRus™
- Founder & CEO – CardioMEMS, Inc.
- Chairman, Cleveland Clinic Foundation Innovations – Cleveland Clinic
- Director, Vascular Intervention – Cleveland Clinic
Education
- Yale University – B.S., Molecular Biophysics and Biochemistry
- Duke University Medical Center – Residency
- University of Alabama at Birmingham – Fellowship, Cardiology and Interventional Cardiology
- West Virginia University School of Medicine – M.D.
